Rejoinder to the ‘Letter to the Editor’ on “Group-by-treatment interaction effects in comparative bioavailability studies”

dc.contributor.authorSchütz, Helmut
dc.contributor.authorBurger, Divan Aristo.
dc.contributor.authorCobo, Erik
dc.contributor.authorDubins, David
dc.contributor.authorFarkas, Tibor
dc.contributor.authorLabes, Detlew
dc.contributor.authorLang, Benjamin
dc.contributor.authorOcana, Jordi
dc.contributor.authorRing, Arne
dc.contributor.authorShitova, Anastasia
dc.contributor.authorStus, Volodymyr
dc.contributor.authorTomashevskiy, Michael
dc.date.accessioned2025-07-21T07:02:19Z
dc.date.issued2025-02
dc.description.abstractNo abstract available.
dc.description.departmentStatistics
dc.description.embargo2025-12-16
dc.description.librarianhj2025
dc.description.sdgNone
dc.description.sponsorshipOpen access funding provided by Medical University of Vienna.
dc.description.urihttps://link.springer.com/journal/12248
dc.identifier.citationSchütz, H., Burger, D.A., Cobo, E. et al. Rejoinder to the ‘Letter to the Editor’ on “Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies”. The AAPS Journal 27, 14 (2025). https://doi.org/10.1208/s12248-024-01008-3.
dc.identifier.issn1550-7416 (online)
dc.identifier.other10.1208/s12248-024-01008-3
dc.identifier.urihttp://hdl.handle.net/2263/103476
dc.language.isoen
dc.publisherSpringer
dc.rights© The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2024. The original publication is available at : https://link.springer.com/journal/12248.
dc.subjectLetter
dc.subjectGoup-by-treatment interaction
dc.titleRejoinder to the ‘Letter to the Editor’ on “Group-by-treatment interaction effects in comparative bioavailability studies”
dc.typePostprint Article

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: